Researchers at Baylor College of Medicine and collaborating institutions have identified a combination therapy for treating triple-negative breast cancer (TNBC) that results in durable tumor regression in an animal model ...
Apr 27, 2022
0
27
Effective combination therapies are urgently needed to treat triple-negative breast cancer (TNBC), which is insensitive to the existing treatment regimens. However, the synergistic potency of traditional small-molecule combinations ...
Apr 12, 2022
0
3
Two Roswell Park Comprehensive Cancer Center oncologists will discuss promising strategies for making breakthrough immunotherapies work for more patients at the annual meeting of the American Association for Cancer Research ...
Apr 11, 2022
0
14
Everybody knows that consuming too much salt is bad for your health. But nobody ever mentions the potential impact of the other condiment in the cruet set: black pepper. Does it have an effect on your health?
Apr 8, 2022
1
96
Cardamonin—a natural compound found in the spice cardamom and other plants—could have therapeutic potential for triple-negative breast cancer, according to a new study using human cancer cells. The findings also show ...
Apr 3, 2022
0
32
A study published in the journal Nature Cancer, carried out within the Cancer Program at the Hospital del Mar Medical Research Institute (IMIM-Hospital del Mar) by the Cancer Stem Cells and Metastasis Dynamics Laboratory, ...
Mar 17, 2022
0
143
An unexpected link between tuberculosis and cancer may lead to new drug treatments for the bacterial disease that kills more than 1.5 million people each year, according to a study led by researchers at Stanford Medicine.
Mar 11, 2022
0
400
An immunotherapy drug called pembrolizumab has been shown to significantly reduce disease recurrence in patients with the most aggressive type of breast cancer, according to results from a phase III clinical trial led by ...
Feb 10, 2022
0
13
A new study by researchers at Yale Cancer Center shows inhibition of the CECR2 gene prevents triple-negative breast cancer from advancing or metastasizing. The discovery is an early step in finding new therapeutics for triple-negative ...
Feb 3, 2022
0
137
Scientific evidence supporting the involvement of the enzyme MAPK4 in cancer growth and resistance to certain therapies has been growing quickly. In a current study published in the journal Nature Communications, a team at ...
Jan 11, 2022
0
88
